HPSE and exocrine pancreatic carcinoma: Heparanase inhibitors may be effective against tumors in which leukocyte-heparanase aids tumor progression, such as colorectal and pancreatic carcinoma (52), but perhaps less effective against other solid tumors which have little heparanase expression in the tumor microenvironment.